[et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.6.5″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ sticky_enabled=”0″]

Collaboration marks the first submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial!!

Read our latest press releases here:

• Progeria Research Foundation Announces Collaboration and Supply Agreement with Eiger BioPharmaceuticals 
• Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria

Zoey and Carly getting their lonafarnib treatment during their latest clinical trial visit to Boston.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]